Skip to content

Pfizer PFE Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin73.5%+1.2pp74.3%+2.4pp73.4%+5.7pp72.1%+13.9pp72.3%+14.2pp
Efficiency
Asset turnover0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.3×0.0×
Liquidity
Current ratio1.2×0.0×1.2×0.0×1.3×+0.3×1.2×+0.3×1.3×+0.2×
Leverage
Debt-to-equity0.7×0.0×0.8×+0.1×0.7×0.0×0.7×0.0×0.7×0.0×
Per Share
Book value per share$15.72-0.6%$15.14-2.2%$16.24+0.4%$15.54+1.0%$15.82-2.3%
Valuation
Market capitalization$159.73B+11.1%$141.57B-5.8%$144.87B-11.7%$138.21B-12.7%$143.71B-8.5%
Price / sales2.5×+0.2×2.3×-0.1×2.3×-0.4×2.2×-0.7×2.3×-0.5×
Price / book1.8×+0.2×1.6×-0.1×1.6×-0.2×1.6×-0.2×1.6×-0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Pfizer's ratios come from?
Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.